tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brian Cheng, 47 are a BUY (75.81%), 13 are a HOLD (20.97%), 2 are a SELL (3.23%).
Analyst Brian Cheng, currently employed at JPMORGAN, carries an average stock price target met ratio of 35.2% that have a potential upside of 14.09% achieved within 44 days.
Brian Cheng’s has documented 122 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PTGX, Protagonist Therapeutics at 04-Mar-2025.
Analyst best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 3/4/2025. The price target of $57 was fulfilled within 7 days with a profit of $18.34 (47.44%) receiving and performance score of 67.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$68
$58.89 (646.43%)
$72
27 days ago
(10-Mar-2025)
1/5 (20%)
$53.71 (375.86%)
75
Buy
$60
$50.89 (558.62%)
$63
30 days ago
(07-Mar-2025)
14/34 (41.18%)
$44.03 (275.70%)
165
Buy
30 days ago
(07-Mar-2025)
3/5 (60%)
$21.39 (65.59%)
559
Buy
$48
$38.89 (426.89%)
$40
1 years 1 months 29 days ago
(08-Feb-2024)
4/8 (50%)
$10.09 (26.62%)
195
Buy
$36
1 years 8 months 23 days ago
(14-Jul-2023)
2/2 (100%)
$15.83 (78.48%)
271
Which stock is Brian Cheng is most bullish on?
Which stock is Brian Cheng is most reserved on?
What Year was the first public recommendation made by Brian Cheng?
